Natalia Herman-Sanchez | Bioinformatics | Young Scientist Award

Posted on by ScienceFather

Ms. Natalia Herman-Sanchez | Bioinformatics | Young Scientist Award

University of Cordoba | Spain

PUBLICATION PROFILE

Orcid

👩‍🔬 INTRODUCTION

Natalia Hermán-Sánchez is a talented pre-doctoral researcher at the University of Córdoba, Spain. She is dedicated to advancing biomedical research, particularly in the study of liver diseases and cancer. Through her work, Hermán-Sánchez is exploring vital molecular processes, such as RNA splicing and SUMOylation, which play key roles in liver cancer development. As an FPU grant recipient, her contributions are shaping the future of scientific research in this critical area.

🎓 EARLY ACADEMIC PURSUITS

Natalia’s academic journey began with a strong foundation in biochemistry at the University of Córdoba, where she earned her Bachelor’s degree in 2020. She then pursued a Master’s degree in Translational Biomedical Research, completed in 2021, and also obtained a diploma in Bioinformatics Analysis from the University Pablo de Olavide in 2024. These accomplishments laid the groundwork for her deep dive into the molecular biology of cancer and liver diseases.

🧑‍💼 PROFESSIONAL ENDEAVORS

Since 2021, Hermán-Sánchez has been working as a pre-doctoral researcher at the University of Córdoba under the FPU grant program. Her professional focus has been centered on understanding liver diseases and hepatocellular carcinoma (HCC). She is specifically investigating the roles of RNA splicing factors and other molecular mechanisms involved in disease progression, with the aim of discovering novel biomarkers and therapeutic targets.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Hermán-Sánchez’s research is at the forefront of liver disease and cancer research. She has contributed significantly to studies on RNA splicing, SUMOylation, and the post-transcriptional regulation of genes in liver cancer. Her work aims to uncover new diagnostic and prognostic markers, with several impactful publications in top-tier journals like Cell Reports and Experimental & Molecular Medicine. Through this research, she is shaping our understanding of liver cancer biology and offering potential pathways for clinical interventions.

🌍 IMPACT AND INFLUENCE

Hermán-Sánchez’s research is making waves in the scientific community, particularly in the study of liver cancer. Her work has been widely cited and has influenced ongoing research in cancer biology and liver diseases. By presenting her findings at major international conferences such as the European Association for the Study of the Liver (EASL), she is contributing to the global conversation on liver cancer and molecular oncology, solidifying her place as an emerging leader in the field.

📚 ACADEMIC CITATIONS AND PUBLICATIONS

Natalia’s growing list of scientific publications reflects her significant contributions to the fields of hepatology and cancer research. Her research on RNA splicing factors in hepatocellular carcinoma has gained significant attention in the scientific community. These publications underscore her potential as a rising star in biomedical research, with a focus on advancing our understanding of cancer and chronic liver diseases.

🏅 HONORS & AWARDS

Throughout her academic journey, Hermán-Sánchez has received recognition for her work, including invitations to present at prestigious scientific events. Her research has earned her several honors and awards, highlighting her potential as a future leader in biomedical research. Her presentations at conferences have been recognized for their scientific merit, showcasing her contributions to liver cancer research.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

As she continues her research, Hermán-Sánchez is poised to make lasting contributions to the field of biomedical science. Her exploration of molecular mechanisms in liver cancer holds the potential to uncover new therapeutic strategies and diagnostic tools, benefiting patients worldwide. Her continued dedication to understanding the biology of liver diseases ensures that her future work will have a profound impact on clinical practices and cancer treatment.

💬 FINAL CONCLUSION

In summary, Natalia Hermán-Sánchez is a promising and impactful researcher whose work is helping to redefine our understanding of liver cancer and disease. Through her academic achievements, professional experience, and groundbreaking research, she is paving the way for new diagnostic and therapeutic approaches that could ultimately improve patient outcomes. Hermán-Sánchez’s future contributions to biomedical research and clinical medicine are poised to leave a lasting legacy in the fight against liver diseases and cancer.

 📚 TOP NOTES PUBLICATIONS

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
    • Authors: Juan L. López-Cánovas, Natalia Hermán-Sánchez, Mercedes del Rio-Moreno, Antonio C. Fuentes-Fayos, Araceli Lara-López, Marina E. Sánchez-Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de la Mata et al.
    • Journal: Experimental & Molecular Medicine
    • Year: 2023-01-06
Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
    • Authors: Juan L. López‐Cánovas, Natalia Hermán‐Sánchez, Maria Trinidad Moreno‐Montilla, Mercedes del Rio‐Moreno, Emilia Alors‐Perez, Marina E. Sánchez‐Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de la Mata et al.
    • Journal: Clinical and Translational Medicine
    • Year: 2022-11
Multidisciplinary Prehabilitation and Postoperative Rehabilitation for Avoiding Complications in Patients Undergoing Resection of Colon Cancer: Rationale, Design, and Methodology of the ONCOFIT Study
    • Authors: Amaro-Gahete, FJ, Javier Jurado, Andrea Cisneros, Pablo Corres, Andres Marmol-Perez, Francisco J. Osuna-Prieto, Manuel Fernández-Escabias, Estela Salcedo, Natalia Hermán-Sánchez, Manuel D. Gahete et al.
    • Journal: Nutrients
    • Year: 2022-11-03
Dysregulation of splicing variants and spliceosome components in breast cancer
    • Authors: Manuel D Gahete, Natalia Herman-Sanchez, Antonio C Fuentes-Fayos, Juan L Lopez-Canovas, Raúl M Luque
    • Journal: Endocrine-Related Cancer
    • Year: 2022-09-01
Morphofunctional and Molecular Assessment of Nutritional Status in Head and Neck Cancer Patients Undergoing Systemic Treatment: Role of Inflammasome in Clinical Nutrition
    • Authors: Soraya León-Idougourram, Jesús M. Pérez-Gómez, Concepción Muñoz Jiménez, Fernando L-López, Gregorio Manzano García, María José Molina Puertas, Natalia Herman-Sánchez, Rosario Alonso-Echague, Alfonso Calañas Continente, María Ángeles Gálvez Moreno et al.
    • Journal: Cancers
    • Year: 2022-01-19

Bohong Chen | Bioinformatics analysis | Best Researcher Award

Posted on by ScienceFather

Mr. Bohong Chen | Bioinformatics analysis | Best Researcher Award

Mr. Bohong Chen at The First Affiliated Hospital of Xi’an Jiaotong University, China

👨‍🎓Professional Profile

🧑‍🔬 Summary

Mr. Bohong Chen is a talented researcher from The First Affiliated Hospital of Xi’an Jiaotong University, China, currently pursuing his PhD with a focus on tumor drug resistance mechanisms, specifically for breast cancer. His work integrates transcriptomics, single-cell bioinformatics, and Mendelian randomization to better understand the molecular foundations of disease. With a strong academic background and multiple published articles in high-impact journals, Mr. Chen is well-equipped to contribute to foundational biomedical research aimed at improving cancer treatment strategies.

👨‍🎓 Education

Mr. Bohong Chen is currently pursuing a PhD at The First Affiliated Hospital of Xi’an Jiaotong University in China, where he focuses on exploring the mechanisms of tumor drug resistance, particularly for breast cancer. Prior to this, he earned his Master’s degree under the supervision of Wu Dapeng, equipping him with strong research skills in bioinformatics and molecular biology.

🏆 Academic Honors

Mr. Chen has received several prestigious academic honors, including a Second-Class Scholarship for two consecutive years and the title of “Excellent Graduate Student” for the 2021 academic year. Additionally, he serves as a reviewer for the SCI journal PLOS ONE, demonstrating his academic contributions.

💻 Technical Skills

With expertise in bioinformatics, Mr. Chen is proficient in using R Language for transcriptomic and single-cell data analysis. His skills also include Mendelian randomization, a method he uses for genetic epidemiology and to explore causal relationships in disease mechanisms. These technical skills form the backbone of his innovative research in tumor drug resistance and other medical conditions.

👨‍🏫 Teaching Experience

In addition to his research, Mr. Chen has demonstrated teaching abilities as a Master’s Supervisor under Wu Dapeng. He assists graduate students in their research and offers valuable guidance in bioinformatics and genomics.

🔬 Research Interests

Mr. Chen’s research interests are primarily focused on understanding tumor drug resistance, especially in breast cancer. He is particularly interested in leveraging advanced bioinformatics techniques such as single-cell sequencing and machine learning to identify novel therapeutic targets. His goal is to provide more effective treatment strategies for cancer patients by exploring the molecular mechanisms behind drug resistance.